← Back to Clinical Trials
Recruiting NCT07114094

NCT07114094 Development, Validation and Evaluation of a Deprescribing Tool

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07114094
Status Recruiting
Phase
Sponsor Indian Council of Medical Research
Condition Elderly
Study Type INTERVENTIONAL
Enrollment 1,650 participants
Start Date 2025-05-01
Primary Completion 2026-02

Trial Parameters

Condition Elderly
Sponsor Indian Council of Medical Research
Study Type INTERVENTIONAL
Phase N/A
Enrollment 1,650
Sex ALL
Min Age 60 Years
Max Age N/A
Start Date 2025-05-01
Completion 2026-02
Interventions
Deprescribing Tool

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if a deprescribing tool can help in reducing prescriptions with potentially inappropriate medications (PIMs), in the Indian elderly population. The main question it aims to answer is- Can inappropriate polypharmacy in elderly patients be reduced through development and implementation of a deprescribing tool relevant to the Indian context? Researchers will compare control arm outcome parameters to see if there is a reduction in Proportion of prescriptions with at least one PIM ( Primary outcome parameter). Participating Prescribers ( Physicians) will be randomized to Control or Intervention arms. Particpating patients will not be randomized, and will receive routine consultation with a Physician who does not use the Deprescribing Tool (Control arm) or a prescriber who uses the Deprescribing tool ( Intervention Arm)

Eligibility Criteria

Inclusion Criteria: * Elderly patients (≥ 60 years) of either sex, visiting the General Medicine/ Community and Family Medicine OPD of the study sites Exclusion Criteria: * Patients not willing to participate in the study

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology